Hints and tips:
Related Special Reports
...While Anderson has warned the revamp will lead to “significant” job cuts, Bayer employees have been supportive....
...Auditory neuropathy can be due to a variation in a single gene — known as the OTOF gene — which produces a protein called otoferlin....
...Anderson “loves” architecture....
...jeremy-anderson.com...
...Former deputy Tory chair Lee Anderson has announced his defection to the Reform UK party at a press conference this morning. The move hands the populist right-wing party its first MP....
...Other gene therapies that treat rare diseases and have few alternative cures can come with high price tags....
...Sunak appointed Anderson as Tory deputy chair in early 2023....
...Speaking before news of Anderson’s suspension, Khan said that it was “unclear” why Sunak and members of his cabinet were not condemning Anderson’s comments. “Racism is racism,” he said....
...EU lawmakers have voted to approve a controversial law that will make it easier for farmers to use gene editing to improve the resilience of crops....
...“If he allows the likes of Anderson to spread hate and division like this, those words will be revealed as a sham.”...
...The treatment targeted the KLKB1 gene, which plays a crucial role in hereditary angioedema....
...Struggling German conglomerate Bayer is “badly broken” and currently unable to split up, chief executive Bill Anderson said on Tuesday....
...Nigel Farage, president of Reform UK, called on Anderson to join his rightwing party, sparking speculation the now independent MP could defect.Sunak appointed Anderson Tory deputy chair last year in a bid...
...Anderson, a former executive at Swiss rival Roche, said he was seeking to “rebase expectations”....
...“That’s news to me,” said Anderson....
...Lenmeldy works by inserting a genetically modified version of the gene that causes MLD in a patient’s blood stem cells and delivering it via an infusion....
...The UK approved Casgevy in November, making it the first country to greenlight a therapy based on Crispr gene editing....
From Tim Anderson, Johannesburg, South Africa
...But the UK has just become the first country to approve a therapy based on Crispr gene editing, authorising a treatment for sickle cell disease and beta thalassemia....
...A senior EU court adviser has said the European Commission was wrong to block gene sequencing group Illumina’s $8bn acquisition of Grail and that the decision should be scrapped....
...Crispr is a flexible and efficient gene editing tool based on the bacterial immune system....
From Andrew Anderson, Edinburgh, UK
...Prof Ezura said the so-called NGTs were far quicker and worked with existing genes rather than introducing others....
...The group’s head of pharma, Stefan Oelrich, who moved to the job from rival Sanofi in 2018, axed 40 per cent of the old R&D programme, focusing on cell and gene therapy and spending billions of euros to...
...Crispr has been applied to blood disorders first because the cells are easier to extract to edit their genes....
International Edition